TL;DR: 7-hydroxymitragynine (7-OH) is a concentrated alkaloid extracted from kratom that’s significantly more potent than whole-leaf products. The FDA recommended Schedule I classification in July 2025, Florida banned it outright in August 2025, and multiple KCPA states cap concentrations at 2%. If you’re stocking high-concentration 7-OH shots, tablets, or extracts, you’re carrying elevated regulatory and liability risk compared to traditional kratom powder. This guide covers what 7-OH is, where it’s legal, and how to evaluate whether it belongs in your product mix.

What Is 7-Hydroxymitragynine?

7-hydroxymitragynine is one of the primary alkaloids found naturally in kratom (Mitragyna speciosa) leaves, but it occurs in very small concentrations in the raw plant material—typically less than 0.02% by weight. The compound acts as a partial opioid agonist and is responsible for much of kratom’s analgesic and euphoric effects.

The products causing regulatory concern aren’t whole-leaf kratom powder. They’re concentrated extracts where manufacturers isolate and concentrate 7-OH to levels 50 to 100 times higher than what occurs naturally. These products are marketed as shots, tablets, capsules, and enhanced powders, often with branding that emphasizes potency: “ultra,” “gold,” “platinum,” or numerical multipliers like “10x” or “50x.”

From a retail perspective, the distinction matters because regulators and lawmakers are increasingly treating concentrated 7-OH products differently than traditional kratom powder and capsules.

The Regulatory Landscape: What Changed in 2025-2026

The 7-OH regulatory situation accelerated rapidly over the past year. Here’s the timeline shop owners need to understand:

July 2025: The FDA formally recommended that the DEA place concentrated 7-hydroxymitragynine into Schedule I of the Controlled Substances Act. The recommendation specifically targeted high-concentration extracts, not whole-leaf kratom. As of mid-2026, the DEA has not acted on this recommendation, but the federal clock is ticking.

August 2025: Florida’s Department of Health issued an emergency rule banning the sale of 7-OH products statewide. The rule cited public health concerns and overdose cases linked to high-concentration extracts. The ban remains in effect.

October 2025: California’s Department of Public Health issued an administrative action creating a de facto commercial ban on kratom and 7-OH products. This wasn’t a legislative ban, but it effectively ended legal retail sales in the state.

2024-2026: Multiple states that passed Kratom Consumer Protection Acts (KCPA) included concentration caps. Arizona, Oklahoma, Colorado, Texas, and Utah all limit 7-OH to 2% of total alkaloid content. This regulatory approach effectively bans high-concentration extracts while keeping traditional kratom products legal and regulated.

The pattern is clear: states are splitting kratom regulation into two categories. Whole-leaf and low-concentration products are being brought into regulated frameworks. High-concentration 7-OH extracts are being restricted or banned outright.

State-by-State Compliance: Where You Can and Can’t Sell

As of mid-2026, here’s where 7-OH and kratom stand:

States with Full Kratom Bans

These states prohibit all kratom products, including 7-OH:

  • Alabama
  • Arkansas
  • Connecticut
  • Indiana
  • Kansas (effective July 2026)
  • Louisiana
  • Michigan
  • Vermont
  • Wisconsin
  • Tennessee (pending governor signature)

California has an administrative ban that functions as a commercial prohibition, even though it’s not a legislative statute.

States with 7-OH Concentration Caps (2% Rule)

These KCPA states allow kratom but cap 7-OH at 2% of total alkaloids, effectively banning high-concentration extracts:

  • Arizona
  • Colorado
  • Oklahoma
  • Texas
  • Utah

State with 7-OH Product Ban

  • Florida (banned 7-OH products entirely, but traditional kratom remains legal under KCPA framework)

States with KCPA Framework (No Concentration Cap)

18+ states have passed KCPA legislation requiring age verification, labeling, and lab testing but don’t currently cap 7-OH concentrations. These states still permit high-concentration products, but that could change via amendment or administrative rule.

Verification Is Your Responsibility

State laws are changing every legislative session. Rhode Island reversed its kratom ban effective April 1, 2026. Kansas enacted a ban effective July 2026. If you operate in multiple locations or source from distributors in other states, consult your state regulator or trade attorney before adding or restocking 7-OH products.

Should You Stock High-Concentration 7-OH Products?

This is a risk-tolerance question, not a blanket yes or no. Here are the factors to weigh:

Margin: High-concentration 7-OH products typically carry better margins than bulk kratom powder. Shots and tablets in the $15-$40 range offer strong per-unit profit.

Customer demand: Some of your existing kratom customers prefer extracts for convenience and potency. If you don’t stock them, they may go to a competitor or an online vendor.

No federal action yet: The DEA has not scheduled 7-OH. Until that happens, it remains legal under federal law.

Arguments Against Stocking

Regulatory trajectory: The FDA recommendation, Florida ban, and KCPA concentration caps all signal that 7-OH is being isolated for restriction. If the DEA schedules it federally, your inventory becomes unsellable overnight.

Liability exposure: Concentrated 7-OH products have been linked to overdose cases and adverse events. Even if you’re not legally liable, the reputational and operational cost of being involved in an incident is real.

Inventory risk: If your state legislature passes a cap or ban mid-session, you may have 30 to 90 days to clear inventory—or none at all if it’s an emergency rule.

Supplier reliability: High-concentration products are more likely to come from suppliers operating in regulatory gray areas. Lab testing, labeling compliance, and GMP standards vary widely. A single bad batch can end your relationship with your payment processor or landlord.

Middle Ground: Low-Concentration Extracts

If you want to offer extract products without the regulatory heat, consider stocking kratom extracts that stay below the 2% 7-OH threshold. Some vendors are reformulating products to meet KCPA caps. These products offer a potency step-up from powder without the compliance risk of ultra-concentrated shots.

Buyer’s Checklist: Vetting 7-OH Products and Vendors

If you decide to stock 7-OH products, here’s your due diligence checklist:

1. Verify Current State Law

Confirm that your state allows 7-OH and check for concentration caps. Don’t rely on your distributor’s legal interpretation—verify independently.

2. Request Third-Party Lab Testing

Every batch should have a certificate of analysis (COA) from an ISO-accredited lab showing:

  • Total alkaloid profile
  • 7-OH concentration as a percentage of total alkaloids
  • Microbial contamination screening
  • Heavy metals screening

If a vendor can’t provide current COAs, walk away.

3. Check Labeling Compliance

KCPA states require specific label elements:

  • Manufacturer or distributor name and contact info
  • Batch or lot number
  • “Kratom” or botanical name on the label
  • Age restriction warning (18+ or 21+ depending on state)
  • Net weight or volume
  • Expiration or manufacturing date

Products without compliant labeling put you at risk during a state inspection.

4. Understand Your Vendor’s Position

Ask your distributor or manufacturer:

  • Are they reformulating to meet 2% caps in KCPA states?
  • Do they have a compliance team monitoring state law changes?
  • What’s their policy if a state bans 7-OH mid-contract?

Vendors who are actively adapting to the regulatory environment are safer long-term partners.

5. Review Your Insurance and Lease Terms

Some liability carriers exclude kratom or kratom extracts. Some commercial leases prohibit the sale of products under FDA review. Confirm you’re covered before you stock.

What to Watch: Signals That Regulatory Action Is Coming

Federal scheduling is the big wildcard. Here’s what to monitor:

DEA public comment periods: If the DEA opens a comment period on 7-OH scheduling, that’s typically a 6-12 month warning before a final rule. Sign up for DEA Federal Register alerts.

State legislative sessions: Most state legislatures meet January through May. Watch for KCPA amendments or emergency rules from state health departments during this window.

Payment processor policy changes: If your credit card processor or POS provider updates their acceptable-use policy to exclude kratom extracts, that’s often a leading indicator of broader industry concern.

Trade association guidance: The American Kratom Association (AKA) and similar groups typically issue alerts when federal or state action is imminent. Join their email lists even if you’re not a member.

Adverse event reports: Media coverage of overdoses or hospitalizations linked to 7-OH products tends to trigger regulatory response within 30-90 days. If you see a cluster of reports in your state, consider pausing reorders until the regulatory dust settles.

Alternatives: Traditional Kratom and Kava

If the 7-OH risk profile doesn’t fit your business model, you still have options in the ethnobotanical category:

Traditional kratom powder and capsules: Whole-leaf kratom remains legal in most states under KCPA frameworks. Margins are thinner, but the regulatory risk is significantly lower.

Kava products: Kava (Piper methysticum) is a completely different plant from kratom. It’s not scheduled federally, and it’s legal in all 50 states. Kava powder, capsules, shots, and drinks are growing fast in smoke shops, and kava bars are emerging as a new retail format. Kava attracts a wellness-oriented customer who may not overlap with your traditional smoke shop clientele, giving you a new traffic source.

Both categories require proper vendor vetting and lab testing, but neither carries the imminent federal scheduling risk that 7-OH does.

Actionable Takeaways for Shop Owners

  • Verify your state’s current law on kratom and 7-OH concentration limits. Don’t assume—confirm with your state regulator or attorney.
  • If you stock high-concentration 7-OH, have an exit plan. Know your distributor’s return policy and how fast you can clear inventory if a ban passes.
  • Prioritize vendors with robust compliance programs. Ask for COAs, GMP certifications, and evidence of ongoing regulatory monitoring.
  • Consider shifting toward KCPA-compliant kratom products (whole-leaf, low-concentration extracts) and kava to reduce regulatory exposure.
  • Monitor federal DEA activity and your state’s legislative calendar. Join trade association lists for early alerts.
  • Review your insurance, lease, and payment processing terms to confirm kratom and kratom extracts are covered.

The 7-OH regulatory environment is moving faster than almost any other category in the smoke shop space. Staying ahead of the curve means treating compliance as a core part of your buying and stocking decisions, not an afterthought.

FAQ

What is the difference between kratom and 7-hydroxymitragynine?
Kratom is the whole leaf or powder from the Mitragyna speciosa tree. 7-hydroxymitragynine (7-OH) is one of the alkaloids naturally present in kratom leaves, but in very small amounts. High-concentration 7-OH products are lab-extracted and concentrated to levels 50-100x higher than what occurs in nature. Regulators are treating concentrated 7-OH differently than traditional kratom powder.

Is 7-hydroxymitragynine legal to sell?
It depends on your state. As of mid-2026, 7-OH is not federally scheduled, but the FDA has recommended Schedule I placement. Florida bans 7-OH products entirely. Arizona, Colorado, Oklahoma, Texas, and Utah cap 7-OH at 2% of total alkaloids, effectively banning high-concentration extracts. States with full kratom bans also prohibit 7-OH. Verify your state’s current law before stocking.

What are KCPA concentration caps?
Several states that passed the Kratom Consumer Protection Act (KCPA) limit 7-hydroxymitragynine to 2% of the total alkaloid content in kratom products. This cap allows traditional kratom powder and low-concentration extracts to remain legal while effectively banning high-potency 7-OH shots and tablets.

Should I stop selling kratom entirely if 7-OH is restricted?
No. Most restrictions target high-concentration 7-OH extracts, not whole-leaf kratom. States with KCPA frameworks regulate traditional kratom powder and capsules with age verification, labeling, and lab testing requirements, but keep them legal. You can continue selling compliant whole-leaf products even if 7-OH extracts are banned or capped in your state.

What should I do if my state passes a 7-OH ban mid-year?
Contact your distributor immediately to understand return or buyback policies. Some vendors will accept returns of banned products; others won’t. Review the effective date of the ban—some states give 30-90 days to clear inventory, while emergency rules may be effective immediately. Consult an attorney if you have significant inventory at risk, and notify your staff to pull affected products from shelves as soon as the ban takes effect.